Recruiting

Telemedicine Education for Caregivers and Asthma Control in Children

Asthma control in pediatric patients remains a critical issue for healthcare providers. Telemedicine has emerged as an effective solution for overcoming distance barriers in healthcare delivery. This study aims to utilize telemedicine-based education for caregivers to improve asthma control in children with uncontrolled asthma. By providing remote guidance and support, the study seeks to enhance caregivers' knowledge and management practices, ultimately leading to better asthma outcomes for pediatric patients.

ClinicalTrials.gov IDNCT06753214

PhaseNA

Enrollment64

SponsorCan Tho University of Medicine and Pharmacy

Age4 Years

SexALL

I'm interested View official listing

Conditions studied

Uncontrolled Asthma, Telemedicine-Based Education

About this study

Interventions

Other: Telemedicine-Based Education — Intervention through telemedicine
Other: Standard Care (in control arm) — Sham comparator through telemedicine

Primary outcomes

The improvement of asthma control (At second follow-up visit (ranging from 4 to 24 weeks after enrollment))

Eligibility information

Inclusion Criteria: * Pediatric asthma patients diagnosed according to the GINA guidelines, classified as having uncontrolled asthma, are managed and followed up for at least 1 month at the pediatric asthma unit of the outpatient department. Exclusion Criteria: * Pediatric patients who do not cooperate or are unable to complete the Childhood Asthma Control Test questionnaire. * Caregivers who cannot complete the questionnaires related to the assessment of asthma control and associated factors. * Pediatric patients who have siblings participating in the study. * Patients currently participating in another clinical study (excluding non-interventional studies or registries). * Failure to return for a second visit within 6 months following enrollment.

Study locations

Can Tho Children's Hospital, Can Tho, 900000 Vietnam

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.